BioLattice Ophthalmics, Inc,

New Filing

CIK: 0002125596·Biotechnology·DELAWARE·Filed: Mar 30, 2026

Total Offering

$2,500,000

Amount Sold

$575,000

Investors

2

First Sale

Mar 6, 2026

Offering Details

Type: Equity
Exemptions: Rule 506(b)
Entity Type: Corporation
Year Incorporated: 2023
Non-Accredited Investors: No

Related Persons

Name	Role
Linda Alunkal	Related Person
Amelia Zellander	Related Person
Gregory Jackson	Related Person

Company

BioLattice Ophthalmics, Inc,

2929 ARCH STREET

PHILADELPHIA, PA, 19104

267-481-5423

SEC Filing

0002125596-26-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.